Month: April 2022

TAAT® Agreement to Acquire Ohio-Based Tobacco Distributor Becomes Definitive

Written by Customer Service on April 21, 2022. Posted in Mergers And Acquisitions.

Picture 1 In the video clip above, various footage from HLND’s facility in Canton, Ohio is shown. The Company is acquiring HLND with an objective of optimizing the TAAT® supply chain to pursue benefits such as enhanced oversight of the movement of TAAT® at the wholesale level in the north-central region of the United States, as well as the opportunity to strengthen its operating margins by handling certain aspects of TAAT® distribution in-house.LAS VEGAS and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that its agreement to acquire HLND Holdings, Inc. (“HLND”), which is to become the Company’s in-house distribution arm for the north-central region of the United States starting this year,...

Active Biotech Interim Report Q1 2022

Written by Customer Service on April 21, 2022. Posted in Earnings Releases And Operating Results.

FIRST QUARTER IN BRIEFDr. Erik Vahtola appointed Chief Medical Officer (Jan 01) First patient dosed in the combination part of the phase Ib/IIa study of tasquinimod in multiple myeloma (Feb 07) Active Biotech entered into global patent license agreement with Oncode Institute for tasquinimod in myelofibrosis (Feb 9)EVENTS AFTER THE END OF THE PERIODLaquinimod eye drop phase I single ascending-dose part in healthy subjects finished with no safety concerns, multiple-dose part startedFinancial summary SEK M Jan-Mar Full-year 2022 2021 2021 Net sales – – – Operating loss/loss -15,3 -9,7 -49,8 Profit/loss after tax -15,7 -9,8 -49,8 Earnings per share (SEK) -0,07 -0,05 -0,24 Cash and cash equivalents (at close of period) 37,8 92,0 53,1 For further information,...

Pheromones Market in Agriculture to value over US$ 12.3 Billion by 2030 – MDC Research

Written by Customer Service on April 21, 2022. Posted in Mergers And Acquisitions.

Pheromones Market in Agriculture by Type (Sex Pheromones and Aggregation Pheromones), Crop Type (Field Crops, Fruits & Nuts and Vegetables Crops), Application (Trapping, Monitoring and Mating Disruption), Mode of Application (Traps, Sprayers and Dispensers) -Analysis & Forecast 2022-2030 Pune, April 21, 2022 (GLOBE NEWSWIRE) — The global pheromones market in agriculture is driven by several factors such as implementation of more sustainable agricultural practices namely, Integrated Pest Management to reduce toxicity inflicted to the environment and improve the overall agricultural production. Moreover, increasing preference of pheromones in agriculture can be attributed to target specificity and ease in application of pheromones. This assists in controlling several forms of pests thereby contributing extensively to the...

Nidec Announces Financial Results for Fiscal Year Ended March 31, 2022

Written by Customer Service on April 21, 2022. Posted in Earnings Releases And Operating Results.

KYOTO, Japan, April 21, 2022 (GLOBE NEWSWIRE) — Nidec Corporation (TSE: 6594) (OTC US: NJDCY) today announced its consolidated financial results under the International Financial Reporting Standards (“IFRS”) for the fiscal year ended March 31, 2022. The highlights are as follows:Net sales stood at a record high of ¥1,918.2 billion, 18.5% higher Y/Y. Operating profit and profit before income taxes increased 7.2% Y/Y to ¥171.5 billion, 11.9% Y/Y to ¥171.1 billion, respectively. Both stood at record high. Profit attributable to owners of the parent stood at a record high of ¥136.9 billion, 12.2% higher Y/Y. EPS: ￥234.30 (basic and diluted)Selected Consolidated Results of Operations (Unaudited) (IFRS-Based)Yen in millions, except for per share amounts and percentages Year ended March 31, Increase(Decrease) % Three months ended...

Proactive news headlines including Astro Resources, Aruma Resources, Valor Resources and Perseus Mining

Written by Customer Service on April 21, 2022. Posted in Mergers And Acquisitions.

Sydney, April 21, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Astro Resources NL (ASX:ARO)’s drilling campaign at the Needles Gold Project in Nevada, USA, has wound up with a fourth drill hole designed to test for possible gold mineralisation within a subsidiary geophysical anomaly. Click here Aruma Resources Ltd (ASX:AAJ) has defined a thick vertical pegmatite with lithium grades up to 1.14% lithium oxide from its maiden drilling program at the Mt Deans Lithium Project in Western Australia. Click here Valor Resources Ltd (ASX:VAL) has doubled down on additional copper targets at its Picha project in southern Peru. Click here Perseus Mining Ltd (ASX:PRU, TSX:PRU, OTC:PMNXF) has provided relevant materials and information...

RoodMicrotec N.V. publishes 2021 annual report with audited financial statements

Written by Customer Service on April 21, 2022. Posted in Earnings Releases And Operating Results.

RoodMicrotec shows strong financial performance for the year 2021, resulting in:Total income of EUR 14.5 million with an EBITDA of EUR 2.8 million Net profit of EUR 1.4 million Cash flow from operating activities of EUR 2.2 millionDeventer, April 21, 2022 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, today publishes the Company’s Annual Report for the financial year 2021 including the audited financial statements. The 2021 Annual Report is available for download on the corporate website: www.roodmicrotec.com/en/investor-relations-en/financial-publications. The total income for 2021 amounted to EUR 14.5 million, which was 22% higher than in 2020. The net result after taxes for 2021 was EUR 1.4 million positive, mainly due to a higher delivery of services during the year. “We were...

Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%

Written by Customer Service on April 21, 2022. Posted in Earnings Releases And Operating Results.

PRESS RELEASE: REGULATED INFORMATION 21 April 2022, 07:00 CEST Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35% Mechelen, Belgium, 21 April 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update for the first quarter of 2022 and the outlook for the full year 2022. Commenting on the Q1 2022 Business Update, Herman Verrelst, Chief Executive Officer of Biocartis,said: “Building on our strong fundamentals, we had a successful start into 2022. Our financial metrics for the first quarter clearly demonstrated our ability to scale. Our commercial cartridge volumes continued to increase globally, with nearly 2,000 Idylla™ instruments installed, increasing product...

Nestlé reports three-month sales for 2022

Written by Customer Service on April 21, 2022. Posted in Public Companies.

[Ad hoc announcement pursuant to art. 53 SIX Listing Rules] This press release is also available in Français (pdf) and Deutsch (pdf) Follow today’s event live 14:00 CEST Investor call audio webcast Full details on our website …………. Vevey, April 21, 2022 Nestlé reports three-month sales for 2022 Organic growth reached 7.6%, with real internal growth (RIG) of 2.4% and pricing of 5.2%. Growth was broad-based across most geographies and categories, with increased pricing, continued momentum in retail sales and a further recovery in out-of-home channels. Total reported sales increased by 5.4% to CHF 22.2 billion (3M-2021: CHF 21.1 billion). Foreign exchange decreased sales by 0.8%. Net divestitures had a negative impact of 1.3%. Portfolio management on track. In April, Nestlé Health Science completed the...

EDENRED : First-quarter 2022 revenue – Excellent start to the year with continued strong momentum in sales and digital innovation

Written by Customer Service on April 21, 2022. Posted in Public Companies.

First-quarter 2022 revenue Excellent start to the year with continued strong momentum in sales and digital innovationEdenred recorded sustained revenue growth in the first quarter, attesting to the relevance of its digital innovation strategy and its commercial success:Operating revenue up 17.3% as reported (+15.3% like-for-like) versus first-quarter 2021, totaling €426 million Double-digit like-for-like revenue growth in all regions and in both main business lines Driven by strong business volume and higher interest rates in some regions, other revenue increased by nearly 30%, from €10 million to €13 million Total revenue of €439 million, up 17.6% as reported (+15.7% like-for-like) Edenred leveraged its unique digital platform following the transformation of its business model:A value proposition broadened by the extension...

Press news Biocartis Group NV: Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference

Written by Customer Service on April 21, 2022. Posted in Earnings Releases And Operating Results.

PRESS RELEASE: 21 April 2022, 07:01 CEST Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference Mechelen, Belgium, 21 April 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announced that its partner SkylineDx will present new data showing that its Merlin Test was able to prospectively reduce more than 37% of surgeries in a non-interventional study for newly diagnosed melanoma patients1. The abstract publication receives a designated oral presentation during the 18th Congress of the European Association of Dermato-oncology (EADO) in Sevilla, Spain (21-23 April 2022). The Merlin Test identifies melanoma patients that have a low risk for nodal metastasis and therefore can...

Month: April 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals